Certis Oncology Collaborates With Science Exchange to Offer On-Demand Access to its Orthotopic PDX Services
October 25, 2018 11:00 ET
|
Certis Oncology Solutions, Inc.
SAN DIEGO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Science Exchange, the leading marketplace for outsourced R&D, and Certis Oncology, a leading provider for preclinical mouse modeling and tumor...
Certis Oncology Partners With Reveal Biosciences to Offer Advanced Pre-Clinical Oncology Services
August 13, 2018 15:30 ET
|
Certis Oncology Solutions, Inc.
SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an...
Certis Oncology Announces CLIA Certification for High-Complexity Testing
July 16, 2018 08:00 ET
|
Certis Oncology Solutions, Inc.
SAN DIEGO, July 16, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions, Inc., a new precision medicine company focused on individualized patient care, today announced that it has received its CLIA...
AntiCancer PDOX Reaches Series A Financing Target, Appoints Board
June 01, 2017 16:24 ET
|
AntiCancer PDOX, Inc.
CHICAGO, June 01, 2017 (GLOBE NEWSWIRE) -- ASCO 2017 -- AntiCancer PDOX, Inc. announced today that it has reached its original Series A financing target and appointed its Board of...